292 related articles for article (PubMed ID: 21196177)
1. Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.
Smith RA; Guleryuz S; Manning HC
Front Biosci (Landmark Ed); 2011 Jan; 16(2):393-410. PubMed ID: 21196177
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging using PET for breast cancer.
Kurihara H; Shimizu C; Miyakita Y; Yoshida M; Hamada A; Kanayama Y; Yonemori K; Hashimoto J; Tani H; Kodaira M; Yunokawa M; Yamamoto H; Watanabe Y; Fujiwara Y; Tamura K
Breast Cancer; 2016 Jan; 23(1):24-32. PubMed ID: 25917108
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.
Buck AK; Herrmann K; Shen C; Dechow T; Schwaiger M; Wester HJ
Methods; 2009 Jun; 48(2):205-15. PubMed ID: 19318128
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis.
García-Figueiras R; Padhani AR; Beer AJ; Baleato-González S; Vilanova JC; Luna A; Oleaga L; Gómez-Caamaño A; Koh DM
Curr Probl Diagn Radiol; 2015; 44(5):407-24. PubMed ID: 25890454
[TBL] [Abstract][Full Text] [Related]
5. Imaging pharmacodynamics in oncology: the potential significance of "flares".
Trigonis I; Jackson A
Ann Nucl Med; 2010 Apr; 24(3):137-47. PubMed ID: 20069468
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of cancer biology: current status and future prospects.
Chen K; Chen X
Semin Oncol; 2011 Feb; 38(1):70-86. PubMed ID: 21362517
[TBL] [Abstract][Full Text] [Related]
7. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
Apostolova I; Wedel F; Brenner W
Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
[TBL] [Abstract][Full Text] [Related]
8. Functional response imaging following neoadjuvant therapy for rectal cancer.
Smeets P; Ceelen W
Surg Technol Int; 2009 Apr; 18():93-7. PubMed ID: 19579194
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging of Breast Cancer: Role of RGD Peptides.
Chakravarty R; Chakraborty S; Dash A
Mini Rev Med Chem; 2015; 15(13):1073-94. PubMed ID: 26349490
[TBL] [Abstract][Full Text] [Related]
10. Thymidine Kinase PET Reporter Gene Imaging of Cancer Cells In Vivo.
McCracken MN
Methods Mol Biol; 2018; 1790():137-151. PubMed ID: 29858789
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness research for molecular imaging.
Graham MM
J Comp Eff Res; 2012 Mar; 1(2):113-4. PubMed ID: 24237368
[No Abstract] [Full Text] [Related]
12. Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.
Cullinane C; Waldeck KL; Binns D; Bogatyreva E; Bradley DP; de Jong R; McArthur GA; Hicks RJ
Nucl Med Biol; 2014 Feb; 41(2):148-54. PubMed ID: 24332383
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging using positron emission tomography in colorectal cancer.
Lin M
Discov Med; 2011 May; 11(60):435-47. PubMed ID: 21616042
[TBL] [Abstract][Full Text] [Related]
14. Applications of PET imaging with the proliferation marker [18F]-FLT.
Peck M; Pollack HA; Friesen A; Muzi M; Shoner SC; Shankland EG; Fink JR; Armstrong JO; Link JM; Krohn KA
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):95-104. PubMed ID: 25737423
[TBL] [Abstract][Full Text] [Related]
15. Visualization, imaging and new preclinical diagnostics in radiation oncology.
Cyran CC; Paprottka PM; Eisenblätter M; Clevert DA; Rist C; Nikolaou K; Lauber K; Wenz F; Hausmann D; Reiser MF; Belka C; Niyazi M
Radiat Oncol; 2014 Jan; 9():3. PubMed ID: 24387195
[TBL] [Abstract][Full Text] [Related]
16. Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
Toumpanakis C; Kim MK; Rinke A; Bergestuen DS; Thirlwell C; Khan MS; Salazar R; Oberg K
Neuroendocrinology; 2014; 99(2):63-74. PubMed ID: 24458014
[TBL] [Abstract][Full Text] [Related]
17. [Functional imaging of tumors. Part 2].
García Figueiras R; Padhani AR; Vilanova JC; Goh V; Villalba Martín C
Radiologia; 2010; 52(3):208-20. PubMed ID: 20304448
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
Sala R; Nguyen QD; Patel CB; Mann D; Steinke JH; Vilar R; Aboagye EO
PLoS One; 2014; 9(7):e101366. PubMed ID: 25003822
[TBL] [Abstract][Full Text] [Related]
19. Use of new imaging techniques to predict tumour response to therapy.
Harry VN; Semple SI; Parkin DE; Gilbert FJ
Lancet Oncol; 2010 Jan; 11(1):92-102. PubMed ID: 20129132
[TBL] [Abstract][Full Text] [Related]
20. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
